Theragenics' sales slide as buyout looms; Kips Bay enrolling FDA-targeted trial;

@FierceMedDev: Alere declares victory in proxy challenge. Article | Follow @FierceMedDev

@DamianFierce: Losses mounting, Invacare sells off another unit for $45M. Story | Follow @DamianFierce

@MichaelGFierce: Luminex axing 5% of workforce as reimbursement dries up. Article | Follow @MichaelGFierce

> Theragenics ($TGX) reported an 8% drop in revenue and another net loss in the second quarter, all as the company waits to be acquired by Juniper for a reported $68 million. Results

> Hologic ($HOLX) has launched a new bone imaging system used to assess osteoporosis, cardiovascular disease and obesity. Release

> Cook Medical has completed enrollment in a study of a new vascular access technique to treat peripheral artery disease. News

> GenMark Diagnostics ($GNMK) snagged $5.2 million in revenue last quarter, a 44% increase, but increased its net loss 42.8% to $8 million. More

> Kips Bay Medical ($KIPS) is enrolling an FDA-targeted trial for its external saphenous vein graft device, designed for use in coronary artery bypass surgeries. Item

> DexCom's ($DXCM) revenue jumped 65% to $35.5 million last quarter, and the diabetes device outfit narrowed its net loss by about 31% to $10.1 million. Financials

Biotech News

@FierceBiotech: Ousted scientist fires back at GSK's high-pressure R&D strategy in China. Story | Follow @FierceBiotech

@JohnCFierce: Is the silly season on biotech IPOs over? No, Intrexon debuts with $2B market value. Item | Follow @JohnCFierce

@RyanMFierce: Biotech M&A gossip: Amgen buyout of Onyx could happen soon. More | Follow @RyanMFierce

@EmilyMFierce: NIH to open genomic data of HeLa cells to researchers. Article | Follow @EmilyMFierce

> GlaxoSmithKline wires up $50M VC fund for bioelectronic treatment effort. Report

> Array slashes staff as Amgen pulls the plug on diabetes drug pact. News

Pharma News

@FiercePharma: Tyson suspends use of Merck growth enhancer for cattle b/c some having difficulty walking. Merck says Zilmax safe. Item | Follow @FiercePharma

@CarlyHFierce: ICYMI: On Vivus' Q2 earnings and plans from new CEO Tony Zook (formerly of AstraZeneca) to increase Qsymia sales. More | Follow @CarlyHFierce

> Sanofi faces bribery allegations from China whistleblower. Story

> Wanted: Buyers for Aptalis Pharma. Must be willing to pay $3B-plus. Article

> Endo invests big in Qualitest to push generic growth. More

Vaccines News

> Flu vaccine tablet developer raises $20M. News

> PharmAthene to add antibody assets in Theraclone merger. Item

> Sanofi advances C. diff vaccine into PhIII. More

> Israel buys 500,000 polio vaccines for immunization push. Article

> GSK adding 2-D barcode to 4-in-1 flu vaccine packaging. Story

> Dana-Farber sees promise in leukemia vaccine trial. More

Pharma Manufacturing News

@EricPFierce: Pharma Tech Industries to expand facility in Missouri. Story | Follow @EricPFierce

> GAO report says FDA needs clear authority over compounders. News

> Ranbaxy gets site for second Malaysian plant. Story

> When it comes to Viagra, counterfeiters just can get enough. Article

> Endo investing $100M in Qualitest manufacturing. More

> Recall expert takes services to Europe. Item

Sponsored By Paraza Pharma

Choosing the Right Pre-Clinical Collaborative Research Organization (CRO)

Learn about the key factors that are essential to creating a collaborative and productive working relationship to advance pre-clinical drug discovery programs.